The implantation of autologous fibroblasts is aimed at those patients who want their skin to look young: still being themselves but turning back time. It is a new biotechnological treatment that is performed after taking a sample of the patient's cells. The objective of the treatment is to create a young cell line able to synthesize collagen without being a foreign product for the body. This allows the patients to rebuild their cells and keep their skin young and healthy.
The method is compatible with other facial rejuvenation techniques such as mesotherapy, radiofrequency, peels, implants and botulinum toxin. It is an ideal treatment for men and women over 40 years old.
The FDA approved the implantation of autologous fibroblasts to treat moderate to severe nasolabial folds in June 2011. Dr. Frisari is the director of the Autologous fibroblasts implants in facial rejuvenation course at Pinto Institute, Buenos Aires, Argentina.